Konopka, K.; Frączek, P.; Lubaś, M.; Micek, A.; Kwinta, Ł.; Streb, J.; Potocki, P.; Wysocki, P.J.
Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer. J. Clin. Med. 2022, 11, 1213.
https://doi.org/10.3390/jcm11051213
AMA Style
Konopka K, Frączek P, Lubaś M, Micek A, Kwinta Ł, Streb J, Potocki P, Wysocki PJ.
Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer. Journal of Clinical Medicine. 2022; 11(5):1213.
https://doi.org/10.3390/jcm11051213
Chicago/Turabian Style
Konopka, Kamil, Paulina Frączek, Maciej Lubaś, Agnieszka Micek, Łukasz Kwinta, Joanna Streb, Paweł Potocki, and Piotr J. Wysocki.
2022. "Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer" Journal of Clinical Medicine 11, no. 5: 1213.
https://doi.org/10.3390/jcm11051213
APA Style
Konopka, K., Frączek, P., Lubaś, M., Micek, A., Kwinta, Ł., Streb, J., Potocki, P., & Wysocki, P. J.
(2022). Reduction of Cancer-Induced Thrombocytosis as a Biomarker of Improved Outcomes in Advanced Gastric Cancer. Journal of Clinical Medicine, 11(5), 1213.
https://doi.org/10.3390/jcm11051213